Literature DB >> 22099268

Sperm retrieval techniques for assisted reproduction.

Sandro C Esteves1, Ricardo Miyaoka, Ashok Agarwal.   

Abstract

Different surgical methods such as PESA, MESA, TESA, TESE and micro-TESE have been developed to retrieve spermatozoa from either the epididymis or the testis according to the type of azoospermia, i.e., obstructive or non-obstructive. Laboratory techniques are used to remove contaminants, cellular debris, and red blood cells following collection of the epididymal fluid or testicular tissue. Surgically-retrieved spermatozoa may be used for intracytoplasmic sperm injection (ICSI) and/or cryopreservation. In this article, we review the surgical procedures for retrieving spermatozoa from both the epididymis and the testicle and provide technical details of the commonly used methods. A critical analysis of the advantages and limitations of the current surgical methods to retrieve sperm from males with obstructive and non-obstructive azoospermia is presented along with an overview of the laboratory techniques routinely used to process surgically-retrieved sperm. Lastly, we summarize the results from the current literature of sperm retrieval, as well as the clinical outcome of ICSI in the clinical scenario of obstructive and nonobstructive azoospermia.

Entities:  

Mesh:

Year:  2011        PMID: 22099268     DOI: 10.1590/s1677-55382011000500002

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  38 in total

Review 1.  Insight into oxidative stress in varicocele-associated male infertility: part 1.

Authors:  Ashok Agarwal; Alaa Hamada; Sandro C Esteves
Journal:  Nat Rev Urol       Date:  2012-11-20       Impact factor: 14.432

Review 2.  Novel concepts in male factor infertility: clinical and laboratory perspectives.

Authors:  Sandro C Esteves
Journal:  J Assist Reprod Genet       Date:  2016-07-16       Impact factor: 3.412

Review 3.  Stem cell therapeutic possibilities: future therapeutic options for male-factor and female-factor infertility?

Authors:  Charles A Easley; Calvin R Simerly; Gerald Schatten
Journal:  Reprod Biomed Online       Date:  2013-03-26       Impact factor: 3.828

4.  Evaluation of preincubation time interval in testicular biopsy to obtain optimum sperm parameters.

Authors:  Yousef-Reza Yousefnia Pasha; Seyed Gholam-Ali Jorsaraei; Mahtab Zeinalzadeh; Masoumeh Golsorkhtabar Amiri; Arsalan-Ali Ramaji
Journal:  Cell J       Date:  2012-06-13       Impact factor: 2.479

5.  Recombinant gonadotropin therapy to improve spermatogenesis in nonobstructive azoospermic patients - A proof of concept study.

Authors:  Rita Jakubcionyte Laursen; Birgit Alsbjerg; Helle Olesen Elbaek; Betina Boel Povlsen; Kirsten Brock Spanggaard Jensen; Jette Lykkegaard; Sandro C Esteves; Peter Humaidan
Journal:  Int Braz J Urol       Date:  2022 May-Jun       Impact factor: 3.050

6.  Laboratory handling of epididymal and testicular spermatozoa: What can be done to improve sperm injections outcome.

Authors:  Sandro C Esteves; Alex C Varghese
Journal:  J Hum Reprod Sci       Date:  2012-09

Review 7.  An update on sperm retrieval techniques for azoospermic males.

Authors:  Sandro C Esteves; Ricardo Miyaoka; José Eduardo Orosz; Ashok Agarwal
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

Review 8.  Reproductive outcomes, including neonatal data, following sperm injection in men with obstructive and nonobstructive azoospermia: case series and systematic review.

Authors:  Sandro C Esteves; Ashok Agarwal
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

Review 9.  Update in the evaluation of the azoospermic male.

Authors:  Ahmet Gudeloglu; Sijo J Parekattil
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

Review 10.  Predictive factors for sperm retrieval and sperm injection outcomes in obstructive azoospermia: do etiology, retrieval techniques and gamete source play a role?

Authors:  Ricardo Miyaoka; Sandro C Esteves
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.